Abstract

5555Background: PARP-inhibitors and anti-angiogenic agents are active substances against ovarian cancer (OC). We investigated the safety, tolerability and Recommended Phase 2 Dose (RP2D) of the com...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Exploratory phase II efficacy study of MORAb-003, a monoclonal antibody against folate receptor alpha, in platinum-sensitive ovarian cancer in first relapse
D K Armstrong ... R H Verheijen
Journal of Clinical Oncology | VOL. 26
D K Armstrong, et. al.D K Armstrong ... R H Verheijen
20 May 2008
Cytoreductive surgery followed by chemotherapy versus chemotherapy alone for recurrent platinum-sensitive epithelial ovarian cancer (SOCceR trial): a multicenter randomised controlled study
Rafli Van De Laar ... Petra Lm Zusterzeel
BMC Cancer | VOL. 14
Rafli Van De Laar, et. al.Rafli Van De Laar ... Petra Lm Zusterzeel
14 Jan 2014
Abstract CT157: An open-label Phase II study of combination of TSR-042, bevacizumab, and niraparib in patients with platinum-resistant ovarian cancer (OC): Cohort A of the OPAL trial
Joyce Liu ... Andrea Wahner Hendrickson
American Journal of Cancer | VOL. 79
Joyce Liu, et. al.Joyce Liu ... Andrea Wahner Hendrickson
01 Jul 2019
430 A phase 1b/II clinical study of AK112, a PD-1/VEGF bispecific antibody, in combination with olaparib in BRCA germline wild-type platinum sensitive recurrent ovarian cancer
Lingying Wu ... Yunxia Li
Journal for ImmunoTherapy of Cancer | VOL. 9
Lingying Wu, et. al.Lingying Wu ... Yunxia Li
01 Nov 2021
View more papers

More From: Journal of Clinical Oncology

Paper Title
Journal
Date
Author
It Mattered Later: A Patient-Turned-Doctor's Perspective on Fertility Loss.
Margaret Cupit-Link
Journal of Clinical Oncology | VOL. -
Margaret Cupit-LinkMargaret Cupit-Link
23 Jul 2024
At the Crossroads of Local and Systemic Treatment of Operable Non-Small Cell Lung Cancer.
Rafal Dziadziuszko ... Witold Rzyman
Journal of Clinical Oncology | VOL. -
Rafal Dziadziuszko, et. al.Rafal Dziadziuszko ... Witold Rzyman
23 Jul 2024
Management of Stage III Non-Small Cell Lung Cancer: ASCO Rapid Recommendation Update.
Megan E Daly ...
Journal of Clinical Oncology | VOL. -
Megan E Daly, et. al.Megan E Daly ...
23 Jul 2024
Sharing the Burden: The Case for Definitive Local Therapy in Place of Immune Checkpoint Blockade for Patients With a Low-Volume Burden of Metastatic Disease.
Connor Lynch ... Ralph R Weichselbaum
Journal of Clinical Oncology | VOL. -
Connor Lynch, et. al.Connor Lynch ... Ralph R Weichselbaum
22 Jul 2024
View more papers